FAC Explorer

Audit 292342

FY End
2023-06-30
Total Expended
$6.84M
Findings
0
Programs
13
Organization: Monell Chemical Senses Center (PA)
Year: 2023 Accepted: 2024-02-27
Auditor: Kreischer Miller

Organization Exclusion Status:

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $362,990 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $167,970 Yes 0
93.855 Allergy, Immunology and Transplantation Research $142,637 Yes 0
10.028 Wildlife Services $138,226 Yes 0
93.213 Research and Training in Complementary and Integrative Health $131,821 Yes 0
93.121 Oral Diseases and Disorders Research $90,279 Yes 0
93.273 Alcohol Research Programs $39,902 Yes 0
99.999 Swri-Dod-Dtra: Subcontract No. N99070n $37,091 - 0
93.837 Cardiovascular Diseases Research $30,486 Yes 0
64.999 Va Medical Center $7,608 Yes 0
99.999 Leidos Inc. - Defense Priority Allocation System $6,305 - 0
93.867 Vision Research $3,557 Yes 0
93.173 Research Related to Deafness and Communication Disorders $3,463 Yes 0

Contacts

Name Title Type
DJCTQA1PR7Q4 Danielle Coyne Auditee
2675194729 Steve Feimster Auditor
No contacts on file

Notes to SEFA

Accounting Policies: The accompanying supplementary schedule of expenditures of federal awards includes the federal grant activity of Monell Chemical Senses Center (Monell) and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). De Minimis Rate Used: N Rate Explanation: Monell has elected not to use the 10 percent de minimis indirect cost rate allowed under the Uniform Guidance.